ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Integrin Alpha 4 Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-13J10038
Home | Market Reports | Health| Pharmacy
Global Integrin Alpha 4 Market Insights Forecast to 2028
BUY CHAPTERS

Global Integrin Alpha 4 Market Research Report 2025

Code: QYRE-Auto-13J10038
Report
January 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Antisense Therapeutics Ltd
Biogen
BioMAS Ltd
Daiichi Sankyo Co Ltd
EA Pharma Co Ltd
Immunwork Inc
Morphic Therapeutic Inc
Protagonist Therapeutics Inc
Takeda Pharmaceutical Co Ltd
Viriom Inc

Integrin Alpha 4 Market

The global market for Integrin Alpha 4 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Integrin Alpha 4 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Integrin Alpha 4 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Integrin Alpha 4 include Amgen Inc, Antisense Therapeutics Ltd, Biogen Inc, BioMAS Ltd, Daiichi Sankyo Co Ltd, EA Pharma Co Ltd, Immunwork Inc, Morphic Therapeutic Inc, Protagonist Therapeutics Inc, Takeda Pharmaceutical Co Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Integrin Alpha 4, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Integrin Alpha 4.
The Integrin Alpha 4 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Integrin Alpha 4 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Integrin Alpha 4 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Integrin Alpha 4 Market Report

Report Metric Details
Report Name Integrin Alpha 4 Market
Segment by Type
  • TE-5232
  • ATL-1102
  • Carotegrast
  • ET-3764
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen Inc, Antisense Therapeutics Ltd, Biogen Inc, BioMAS Ltd, Daiichi Sankyo Co Ltd, EA Pharma Co Ltd, Immunwork Inc, Morphic Therapeutic Inc, Protagonist Therapeutics Inc, Takeda Pharmaceutical Co Ltd, Viriom Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Integrin Alpha 4 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Integrin Alpha 4 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Integrin Alpha 4 Market report?

Ans: The main players in the Integrin Alpha 4 Market are Amgen Inc, Antisense Therapeutics Ltd, Biogen Inc, BioMAS Ltd, Daiichi Sankyo Co Ltd, EA Pharma Co Ltd, Immunwork Inc, Morphic Therapeutic Inc, Protagonist Therapeutics Inc, Takeda Pharmaceutical Co Ltd, Viriom Inc

What are the Application segmentation covered in the Integrin Alpha 4 Market report?

Ans: The Applications covered in the Integrin Alpha 4 Market report are Acute Ischemic Stroke, Celiac Disease, Epilepsy, Melanoma, Multiple Sclerosis, Other

What are the Type segmentation covered in the Integrin Alpha 4 Market report?

Ans: The Types covered in the Integrin Alpha 4 Market report are TE-5232, ATL-1102, Carotegrast, ET-3764, Others

Recommended Reports

Neuroscience Therapeutics

Targeted Drug Therapy

Biopharma & Cell Therapy

1 Integrin Alpha 4 Market Overview
1.1 Product Definition
1.2 Integrin Alpha 4 by Type
1.2.1 Global Integrin Alpha 4 Market Value Comparison by Type (2024 VS 2031)
1.2.2 TE-5232
1.2.3 ATL-1102
1.2.4 Carotegrast
1.2.5 ET-3764
1.2.6 Others
1.3 Integrin Alpha 4 by Application
1.3.1 Global Integrin Alpha 4 Market Value by Application (2024 VS 2031)
1.3.2 Acute Ischemic Stroke
1.3.3 Celiac Disease
1.3.4 Epilepsy
1.3.5 Melanoma
1.3.6 Multiple Sclerosis
1.3.7 Other
1.4 Global Integrin Alpha 4 Market Size Estimates and Forecasts
1.4.1 Global Integrin Alpha 4 Revenue 2020-2031
1.4.2 Global Integrin Alpha 4 Sales 2020-2031
1.4.3 Global Integrin Alpha 4 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Integrin Alpha 4 Market Competition by Manufacturers
2.1 Global Integrin Alpha 4 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Integrin Alpha 4 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Integrin Alpha 4 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Integrin Alpha 4, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Integrin Alpha 4, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Integrin Alpha 4, Product Type & Application
2.7 Global Key Manufacturers of Integrin Alpha 4, Date of Enter into This Industry
2.8 Global Integrin Alpha 4 Market Competitive Situation and Trends
2.8.1 Global Integrin Alpha 4 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Integrin Alpha 4 Players Market Share by Revenue
2.8.3 Global Integrin Alpha 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Integrin Alpha 4 Market Scenario by Region
3.1 Global Integrin Alpha 4 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Integrin Alpha 4 Sales by Region: 2020-2031
3.2.1 Global Integrin Alpha 4 Sales by Region: 2020-2025
3.2.2 Global Integrin Alpha 4 Sales by Region: 2026-2031
3.3 Global Integrin Alpha 4 Revenue by Region: 2020-2031
3.3.1 Global Integrin Alpha 4 Revenue by Region: 2020-2025
3.3.2 Global Integrin Alpha 4 Revenue by Region: 2026-2031
3.4 North America Integrin Alpha 4 Market Facts & Figures by Country
3.4.1 North America Integrin Alpha 4 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Integrin Alpha 4 Sales by Country (2020-2031)
3.4.3 North America Integrin Alpha 4 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Integrin Alpha 4 Market Facts & Figures by Country
3.5.1 Europe Integrin Alpha 4 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Integrin Alpha 4 Sales by Country (2020-2031)
3.5.3 Europe Integrin Alpha 4 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Integrin Alpha 4 Market Facts & Figures by Region
3.6.1 Asia Pacific Integrin Alpha 4 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Integrin Alpha 4 Sales by Region (2020-2031)
3.6.3 Asia Pacific Integrin Alpha 4 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Integrin Alpha 4 Market Facts & Figures by Country
3.7.1 Latin America Integrin Alpha 4 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Integrin Alpha 4 Sales by Country (2020-2031)
3.7.3 Latin America Integrin Alpha 4 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Integrin Alpha 4 Market Facts & Figures by Country
3.8.1 Middle East and Africa Integrin Alpha 4 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Integrin Alpha 4 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Integrin Alpha 4 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Integrin Alpha 4 Sales by Type (2020-2031)
4.1.1 Global Integrin Alpha 4 Sales by Type (2020-2025)
4.1.2 Global Integrin Alpha 4 Sales by Type (2026-2031)
4.1.3 Global Integrin Alpha 4 Sales Market Share by Type (2020-2031)
4.2 Global Integrin Alpha 4 Revenue by Type (2020-2031)
4.2.1 Global Integrin Alpha 4 Revenue by Type (2020-2025)
4.2.2 Global Integrin Alpha 4 Revenue by Type (2026-2031)
4.2.3 Global Integrin Alpha 4 Revenue Market Share by Type (2020-2031)
4.3 Global Integrin Alpha 4 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Integrin Alpha 4 Sales by Application (2020-2031)
5.1.1 Global Integrin Alpha 4 Sales by Application (2020-2025)
5.1.2 Global Integrin Alpha 4 Sales by Application (2026-2031)
5.1.3 Global Integrin Alpha 4 Sales Market Share by Application (2020-2031)
5.2 Global Integrin Alpha 4 Revenue by Application (2020-2031)
5.2.1 Global Integrin Alpha 4 Revenue by Application (2020-2025)
5.2.2 Global Integrin Alpha 4 Revenue by Application (2026-2031)
5.2.3 Global Integrin Alpha 4 Revenue Market Share by Application (2020-2031)
5.3 Global Integrin Alpha 4 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen Inc
6.1.1 Amgen Inc Company Information
6.1.2 Amgen Inc Description and Business Overview
6.1.3 Amgen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Inc Integrin Alpha 4 Product Portfolio
6.1.5 Amgen Inc Recent Developments/Updates
6.2 Antisense Therapeutics Ltd
6.2.1 Antisense Therapeutics Ltd Company Information
6.2.2 Antisense Therapeutics Ltd Description and Business Overview
6.2.3 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio
6.2.5 Antisense Therapeutics Ltd Recent Developments/Updates
6.3 Biogen Inc
6.3.1 Biogen Inc Company Information
6.3.2 Biogen Inc Description and Business Overview
6.3.3 Biogen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biogen Inc Integrin Alpha 4 Product Portfolio
6.3.5 Biogen Inc Recent Developments/Updates
6.4 BioMAS Ltd
6.4.1 BioMAS Ltd Company Information
6.4.2 BioMAS Ltd Description and Business Overview
6.4.3 BioMAS Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BioMAS Ltd Integrin Alpha 4 Product Portfolio
6.4.5 BioMAS Ltd Recent Developments/Updates
6.5 Daiichi Sankyo Co Ltd
6.5.1 Daiichi Sankyo Co Ltd Company Information
6.5.2 Daiichi Sankyo Co Ltd Description and Business Overview
6.5.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio
6.5.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
6.6 EA Pharma Co Ltd
6.6.1 EA Pharma Co Ltd Company Information
6.6.2 EA Pharma Co Ltd Description and Business Overview
6.6.3 EA Pharma Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio
6.6.5 EA Pharma Co Ltd Recent Developments/Updates
6.7 Immunwork Inc
6.7.1 Immunwork Inc Company Information
6.7.2 Immunwork Inc Description and Business Overview
6.7.3 Immunwork Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Immunwork Inc Integrin Alpha 4 Product Portfolio
6.7.5 Immunwork Inc Recent Developments/Updates
6.8 Morphic Therapeutic Inc
6.8.1 Morphic Therapeutic Inc Company Information
6.8.2 Morphic Therapeutic Inc Description and Business Overview
6.8.3 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio
6.8.5 Morphic Therapeutic Inc Recent Developments/Updates
6.9 Protagonist Therapeutics Inc
6.9.1 Protagonist Therapeutics Inc Company Information
6.9.2 Protagonist Therapeutics Inc Description and Business Overview
6.9.3 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio
6.9.5 Protagonist Therapeutics Inc Recent Developments/Updates
6.10 Takeda Pharmaceutical Co Ltd
6.10.1 Takeda Pharmaceutical Co Ltd Company Information
6.10.2 Takeda Pharmaceutical Co Ltd Description and Business Overview
6.10.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio
6.10.5 Takeda Pharmaceutical Co Ltd Recent Developments/Updates
6.11 Viriom Inc
6.11.1 Viriom Inc Company Information
6.11.2 Viriom Inc Description and Business Overview
6.11.3 Viriom Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Viriom Inc Integrin Alpha 4 Product Portfolio
6.11.5 Viriom Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Integrin Alpha 4 Industry Chain Analysis
7.2 Integrin Alpha 4 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Integrin Alpha 4 Production Mode & Process Analysis
7.4 Integrin Alpha 4 Sales and Marketing
7.4.1 Integrin Alpha 4 Sales Channels
7.4.2 Integrin Alpha 4 Distributors
7.5 Integrin Alpha 4 Customer Analysis
8 Integrin Alpha 4 Market Dynamics
8.1 Integrin Alpha 4 Industry Trends
8.2 Integrin Alpha 4 Market Drivers
8.3 Integrin Alpha 4 Market Challenges
8.4 Integrin Alpha 4 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Antisense Therapeutics Ltd
Biogen
BioMAS Ltd
Daiichi Sankyo Co Ltd
EA Pharma Co Ltd
Immunwork Inc
Morphic Therapeutic Inc
Protagonist Therapeutics Inc
Takeda Pharmaceutical Co Ltd
Viriom Inc
List of Tables
 Table 1. Global Integrin Alpha 4 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Integrin Alpha 4 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Integrin Alpha 4 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Integrin Alpha 4 Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Integrin Alpha 4 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Integrin Alpha 4 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Integrin Alpha 4 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Integrin Alpha 4 Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Integrin Alpha 4, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Integrin Alpha 4, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Integrin Alpha 4, Product Type & Application
 Table 12. Global Key Manufacturers of Integrin Alpha 4, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Integrin Alpha 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Integrin Alpha 4 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Integrin Alpha 4 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Integrin Alpha 4 Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Integrin Alpha 4 Sales Market Share by Region (2020-2025)
 Table 19. Global Integrin Alpha 4 Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Integrin Alpha 4 Sales Market Share by Region (2026-2031)
 Table 21. Global Integrin Alpha 4 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Integrin Alpha 4 Revenue Market Share by Region (2020-2025)
 Table 23. Global Integrin Alpha 4 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Integrin Alpha 4 Revenue Market Share by Region (2026-2031)
 Table 25. North America Integrin Alpha 4 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Integrin Alpha 4 Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Integrin Alpha 4 Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Integrin Alpha 4 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Integrin Alpha 4 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Integrin Alpha 4 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Integrin Alpha 4 Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Integrin Alpha 4 Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Integrin Alpha 4 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Integrin Alpha 4 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Integrin Alpha 4 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Integrin Alpha 4 Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Integrin Alpha 4 Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Integrin Alpha 4 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Integrin Alpha 4 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Integrin Alpha 4 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Integrin Alpha 4 Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Integrin Alpha 4 Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Integrin Alpha 4 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Integrin Alpha 4 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Integrin Alpha 4 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Integrin Alpha 4 Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Integrin Alpha 4 Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Integrin Alpha 4 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Integrin Alpha 4 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Integrin Alpha 4 Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Integrin Alpha 4 Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Integrin Alpha 4 Sales Market Share by Type (2020-2025)
 Table 53. Global Integrin Alpha 4 Sales Market Share by Type (2026-2031)
 Table 54. Global Integrin Alpha 4 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Integrin Alpha 4 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Integrin Alpha 4 Revenue Market Share by Type (2020-2025)
 Table 57. Global Integrin Alpha 4 Revenue Market Share by Type (2026-2031)
 Table 58. Global Integrin Alpha 4 Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Integrin Alpha 4 Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Integrin Alpha 4 Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Integrin Alpha 4 Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Integrin Alpha 4 Sales Market Share by Application (2020-2025)
 Table 63. Global Integrin Alpha 4 Sales Market Share by Application (2026-2031)
 Table 64. Global Integrin Alpha 4 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Integrin Alpha 4 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Integrin Alpha 4 Revenue Market Share by Application (2020-2025)
 Table 67. Global Integrin Alpha 4 Revenue Market Share by Application (2026-2031)
 Table 68. Global Integrin Alpha 4 Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Integrin Alpha 4 Price (USD/Pcs) by Application (2026-2031)
 Table 70. Amgen Inc Company Information
 Table 71. Amgen Inc Description and Business Overview
 Table 72. Amgen Inc Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Amgen Inc Integrin Alpha 4 Product
 Table 74. Amgen Inc Recent Developments/Updates
 Table 75. Antisense Therapeutics Ltd Company Information
 Table 76. Antisense Therapeutics Ltd Description and Business Overview
 Table 77. Antisense Therapeutics Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Antisense Therapeutics Ltd Integrin Alpha 4 Product
 Table 79. Antisense Therapeutics Ltd Recent Developments/Updates
 Table 80. Biogen Inc Company Information
 Table 81. Biogen Inc Description and Business Overview
 Table 82. Biogen Inc Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Biogen Inc Integrin Alpha 4 Product
 Table 84. Biogen Inc Recent Developments/Updates
 Table 85. BioMAS Ltd Company Information
 Table 86. BioMAS Ltd Description and Business Overview
 Table 87. BioMAS Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. BioMAS Ltd Integrin Alpha 4 Product
 Table 89. BioMAS Ltd Recent Developments/Updates
 Table 90. Daiichi Sankyo Co Ltd Company Information
 Table 91. Daiichi Sankyo Co Ltd Description and Business Overview
 Table 92. Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Daiichi Sankyo Co Ltd Integrin Alpha 4 Product
 Table 94. Daiichi Sankyo Co Ltd Recent Developments/Updates
 Table 95. EA Pharma Co Ltd Company Information
 Table 96. EA Pharma Co Ltd Description and Business Overview
 Table 97. EA Pharma Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. EA Pharma Co Ltd Integrin Alpha 4 Product
 Table 99. EA Pharma Co Ltd Recent Developments/Updates
 Table 100. Immunwork Inc Company Information
 Table 101. Immunwork Inc Description and Business Overview
 Table 102. Immunwork Inc Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Immunwork Inc Integrin Alpha 4 Product
 Table 104. Immunwork Inc Recent Developments/Updates
 Table 105. Morphic Therapeutic Inc Company Information
 Table 106. Morphic Therapeutic Inc Description and Business Overview
 Table 107. Morphic Therapeutic Inc Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Morphic Therapeutic Inc Integrin Alpha 4 Product
 Table 109. Morphic Therapeutic Inc Recent Developments/Updates
 Table 110. Protagonist Therapeutics Inc Company Information
 Table 111. Protagonist Therapeutics Inc Description and Business Overview
 Table 112. Protagonist Therapeutics Inc Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Protagonist Therapeutics Inc Integrin Alpha 4 Product
 Table 114. Protagonist Therapeutics Inc Recent Developments/Updates
 Table 115. Takeda Pharmaceutical Co Ltd Company Information
 Table 116. Takeda Pharmaceutical Co Ltd Description and Business Overview
 Table 117. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product
 Table 119. Takeda Pharmaceutical Co Ltd Recent Developments/Updates
 Table 120. Viriom Inc Company Information
 Table 121. Viriom Inc Description and Business Overview
 Table 122. Viriom Inc Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Viriom Inc Integrin Alpha 4 Product
 Table 124. Viriom Inc Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Integrin Alpha 4 Distributors List
 Table 128. Integrin Alpha 4 Customers List
 Table 129. Integrin Alpha 4 Market Trends
 Table 130. Integrin Alpha 4 Market Drivers
 Table 131. Integrin Alpha 4 Market Challenges
 Table 132. Integrin Alpha 4 Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Integrin Alpha 4
 Figure 2. Global Integrin Alpha 4 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Integrin Alpha 4 Market Share by Type: 2024 & 2031
 Figure 4. TE-5232 Product Picture
 Figure 5. ATL-1102 Product Picture
 Figure 6. Carotegrast Product Picture
 Figure 7. ET-3764 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Integrin Alpha 4 Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Integrin Alpha 4 Market Share by Application: 2024 & 2031
 Figure 11. Acute Ischemic Stroke
 Figure 12. Celiac Disease
 Figure 13. Epilepsy
 Figure 14. Melanoma
 Figure 15. Multiple Sclerosis
 Figure 16. Other
 Figure 17. Global Integrin Alpha 4 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Integrin Alpha 4 Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Integrin Alpha 4 Sales (2020-2031) & (K Pcs)
 Figure 20. Global Integrin Alpha 4 Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Integrin Alpha 4 Report Years Considered
 Figure 22. Integrin Alpha 4 Sales Share by Manufacturers in 2024
 Figure 23. Global Integrin Alpha 4 Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Integrin Alpha 4 Players: Market Share by Revenue in Integrin Alpha 4 in 2024
 Figure 25. Integrin Alpha 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Integrin Alpha 4 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Integrin Alpha 4 Sales Market Share by Country (2020-2031)
 Figure 28. North America Integrin Alpha 4 Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Integrin Alpha 4 Sales Market Share by Country (2020-2031)
 Figure 32. Europe Integrin Alpha 4 Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Integrin Alpha 4 Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Integrin Alpha 4 Revenue Market Share by Region (2020-2031)
 Figure 40. China Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Integrin Alpha 4 Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Integrin Alpha 4 Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Integrin Alpha 4 Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Integrin Alpha 4 Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. U.A.E Integrin Alpha 4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Integrin Alpha 4 by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Integrin Alpha 4 by Type (2020-2031)
 Figure 62. Global Integrin Alpha 4 Price (USD/Pcs) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Integrin Alpha 4 by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Integrin Alpha 4 by Application (2020-2031)
 Figure 65. Global Integrin Alpha 4 Price (USD/Pcs) by Application (2020-2031)
 Figure 66. Integrin Alpha 4 Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Integrin Beta 3 Market Research Report 2024
Global Integrin Beta3 Protein Market Research Report 2024
Global Integrin Beta3 Antibody Market Research Report 2024
Global Intercellular Adhesion Molecule 1 Market Research Report 2025
Global Interleukin 1 Alpha Market Research Report 2024
Global Ready to Use Antibodies Market Research Report 2025
Global Antibodies Market Research Report 2024
Recombinant Human Fibronectin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 4 ADPA Market Research Report 2025
Global Peripheral Intervention Products Market Research Report 2024
Global Antibody Array Market Research Report 2025
Global Research Antibodies Market Research Report 2025
Global Enoxaparin Sodium For Injection Market Research Report 2025
Global Human Integrin Beta 3 Market Research Report 2024
Global Human Integrin Beta3 Antibody Market Research Report 2024
Global Protein A Ligand Market Research Report 2024
Global Glycoprotein Analysis Market Research Report 2024
Global Sheath Fluid Market Research Report 2024
Global Adhesion Improver Market Research Report 2025
Global In Vitro Screening Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions